509 related articles for article (PubMed ID: 23045481)
21. S100B Inhibition Attenuates Intestinal Damage and Diarrhea Severity During
Costa DVS; Moura-Neto V; Bolick DT; Guerrant RL; Fawad JA; Shin JH; Medeiros PHQS; Ledwaba SE; Kolling GL; Martins CS; Venkataraman V; Warren CA; Brito GAC
Front Cell Infect Microbiol; 2021; 11():739874. PubMed ID: 34568098
[TBL] [Abstract][Full Text] [Related]
22. A novel multivalent, single-domain antibody targeting TcdA and TcdB prevents fulminant Clostridium difficile infection in mice.
Yang Z; Schmidt D; Liu W; Li S; Shi L; Sheng J; Chen K; Yu H; Tremblay JM; Chen X; Piepenbrink KH; Sundberg EJ; Kelly CP; Bai G; Shoemaker CB; Feng H
J Infect Dis; 2014 Sep; 210(6):964-72. PubMed ID: 24683195
[TBL] [Abstract][Full Text] [Related]
23. The roles of toxin A and toxin B in Clostridium difficile infection: insights from the gnotobiotic piglet model.
Steele J; Parry N; Tzipori S
Gut Microbes; 2014; 5(1):53-7. PubMed ID: 24394234
[TBL] [Abstract][Full Text] [Related]
24. Human peptide α-defensin-1 interferes with Clostridioides difficile toxins TcdA, TcdB, and CDT.
Fischer S; Ückert AK; Landenberger M; Papatheodorou P; Hoffmann-Richter C; Mittler AK; Ziener U; Hägele M; Schwan C; Müller M; Kleger A; Benz R; Popoff MR; Aktories K; Barth H
FASEB J; 2020 May; 34(5):6244-6261. PubMed ID: 32190927
[TBL] [Abstract][Full Text] [Related]
25. In vivo physiological and transcriptional profiling reveals host responses to Clostridium difficile toxin A and toxin B.
D'Auria KM; Kolling GL; Donato GM; Warren CA; Gray MC; Hewlett EL; Papin JA
Infect Immun; 2013 Oct; 81(10):3814-24. PubMed ID: 23897615
[TBL] [Abstract][Full Text] [Related]
26. Vitamin D
Chan H; Li Q; Wang X; Liu WY; Hu W; Zeng J; Xie C; Kwong TNY; Ho IHT; Liu X; Chen H; Yu J; Ko H; Chan RCY; Ip M; Gin T; Cheng ASL; Zhang L; Chan MTV; Wong SH; Wu WKK
Autophagy; 2022 Sep; 18(9):2050-2067. PubMed ID: 34989311
[No Abstract] [Full Text] [Related]
27. Novel Clostridium difficile Anti-Toxin (TcdA and TcdB) Humanized Monoclonal Antibodies Demonstrate In Vitro Neutralization across a Broad Spectrum of Clinical Strains and In Vivo Potency in a Hamster Spore Challenge Model.
Qiu H; Cassan R; Johnstone D; Han X; Joyee AG; McQuoid M; Masi A; Merluza J; Hrehorak B; Reid R; Kennedy K; Tighe B; Rak C; Leonhardt M; Dupas B; Saward L; Berry JD; Nykiforuk CL
PLoS One; 2016; 11(6):e0157970. PubMed ID: 27336843
[TBL] [Abstract][Full Text] [Related]
28. Persistence and toxin production by Clostridium difficile within human intestinal organoids result in disruption of epithelial paracellular barrier function.
Leslie JL; Huang S; Opp JS; Nagy MS; Kobayashi M; Young VB; Spence JR
Infect Immun; 2015 Jan; 83(1):138-45. PubMed ID: 25312952
[TBL] [Abstract][Full Text] [Related]
29. A chimeric toxin vaccine protects against primary and recurrent Clostridium difficile infection.
Wang H; Sun X; Zhang Y; Li S; Chen K; Shi L; Nie W; Kumar R; Tzipori S; Wang J; Savidge T; Feng H
Infect Immun; 2012 Aug; 80(8):2678-88. PubMed ID: 22615245
[TBL] [Abstract][Full Text] [Related]
30. Identification of an epithelial cell receptor responsible for Clostridium difficile TcdB-induced cytotoxicity.
LaFrance ME; Farrow MA; Chandrasekaran R; Sheng J; Rubin DH; Lacy DB
Proc Natl Acad Sci U S A; 2015 Jun; 112(22):7073-8. PubMed ID: 26038560
[TBL] [Abstract][Full Text] [Related]
31. The protective effect of recombinant Lactococcus lactis oral vaccine on a Clostridium difficile-infected animal model.
Yang XQ; Zhao YG; Chen XQ; Jiang B; Sun DY
BMC Gastroenterol; 2013 Jul; 13():117. PubMed ID: 23865596
[TBL] [Abstract][Full Text] [Related]
32. Development of a recombinant toxin fragment vaccine for Clostridium difficile infection.
Karczewski J; Zorman J; Wang S; Miezeiewski M; Xie J; Soring K; Petrescu I; Rogers I; Thiriot DS; Cook JC; Chamberlin M; Xoconostle RF; Nahas DD; Joyce JG; Bodmer JL; Heinrichs JH; Secore S
Vaccine; 2014 May; 32(24):2812-8. PubMed ID: 24662701
[TBL] [Abstract][Full Text] [Related]
33. Transforming Growth Factor β1/SMAD Signaling Pathway Activation Protects the Intestinal Epithelium from Clostridium difficile Toxin A-Induced Damage.
Tinoco-Veras CM; Santos AAQA; Stipursky J; Meloni M; Araujo APB; Foschetti DA; López-Ureña D; Quesada-Gómez C; Leitão RFC; Gomes FCA; Brito GAC
Infect Immun; 2017 Oct; 85(10):. PubMed ID: 28784928
[No Abstract] [Full Text] [Related]
34. P2X7 receptor blockade decreases inflammation, apoptosis, and enteric neuron loss during
Santos AAQA; Costa DVS; Foschetti DA; Duarte ASG; Martins CS; Soares PMG; Castelucci P; Brito GAC
World J Gastroenterol; 2022 Aug; 28(30):4075-4088. PubMed ID: 36157120
[TBL] [Abstract][Full Text] [Related]
35. A DNA vaccine targeting TcdA and TcdB induces protective immunity against Clostridium difficile.
Zhang BZ; Cai J; Yu B; Hua Y; Lau CC; Kao RY; Sze KH; Yuen KY; Huang JD
BMC Infect Dis; 2016 Oct; 16(1):596. PubMed ID: 27770789
[TBL] [Abstract][Full Text] [Related]
36. Development of a Novel Vaccine Containing Binary Toxin for the Prevention of Clostridium difficile Disease with Enhanced Efficacy against NAP1 Strains.
Secore S; Wang S; Doughtry J; Xie J; Miezeiewski M; Rustandi RR; Horton M; Xoconostle R; Wang B; Lancaster C; Kristopeit A; Wang SC; Christanti S; Vitelli S; Gentile MP; Goerke A; Skinner J; Strable E; Thiriot DS; Bodmer JL; Heinrichs JH
PLoS One; 2017; 12(1):e0170640. PubMed ID: 28125650
[TBL] [Abstract][Full Text] [Related]
37. Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production.
Merrigan M; Venugopal A; Mallozzi M; Roxas B; Viswanathan VK; Johnson S; Gerding DN; Vedantam G
J Bacteriol; 2010 Oct; 192(19):4904-11. PubMed ID: 20675495
[TBL] [Abstract][Full Text] [Related]
38. CdtR Regulates TcdA and TcdB Production in Clostridium difficile.
Lyon SA; Hutton ML; Rood JI; Cheung JK; Lyras D
PLoS Pathog; 2016 Jul; 12(7):e1005758. PubMed ID: 27414650
[TBL] [Abstract][Full Text] [Related]
39. The Role of Rho GTPases in Toxicity of Clostridium difficile Toxins.
Chen S; Sun C; Wang H; Wang J
Toxins (Basel); 2015 Dec; 7(12):5254-67. PubMed ID: 26633511
[TBL] [Abstract][Full Text] [Related]
40. Systematic Evaluation of Parameters Important for Production of Native Toxin A and Toxin B from
Aminzadeh A; Jørgensen R
Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33801738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
